Legal & General Group Plc - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 85 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$21,836
-4.8%
2,733
+3.4%
0.00%
Q2 2023$22,946
+195.9%
2,6420.0%0.00%
Q1 2023$7,755
-16.1%
2,6420.0%0.00%
Q4 2022$9,247
-56.0%
2,6420.0%0.00%
Q3 2022$21,0000.0%2,6420.0%0.00%
Q2 2022$21,000
-16.0%
2,642
+30.1%
0.00%
Q1 2022$25,000
+19.0%
2,031
+20.3%
0.00%
Q4 2021$21,000
+16.7%
1,6880.0%0.00%
Q3 2021$18,0001,6880.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,190,921$36,461,01327.59%
ACUTA CAPITAL PARTNERS, LLC 382,000$3,323,4002.25%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,423,897$29,787,9041.59%
Cormorant Asset Management, LP 3,200,000$27,840,0001.56%
Caligan Partners LP 310,298$2,699,5931.52%
Samsara BioCapital, LLC 432,000$3,758,4000.66%
RA Capital Management 3,370,506$29,323,4020.55%
SECTORAL ASSET MANAGEMENT INC 311,277$2,708,1100.45%
ESSEX INVESTMENT MANAGEMENT CO LLC 209,949$1,826,5560.26%
BARD ASSOCIATES INC 30,674$266,8640.10%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders